Zynerba Pharmaceuticals, Inc.·4

Feb 3, 4:32 PM ET

Sebree Terri B 4

4 · Zynerba Pharmaceuticals, Inc. · Filed Feb 3, 2020

Insider Transaction Report

Form 4
Period: 2020-01-30
Transactions
  • Award

    Stock Option (right to buy)

    2020-01-30+120,000120,000 total
    Exercise: $5.05Exp: 2030-01-30Common Stock (120,000 underlying)
Footnotes (1)
  • [F1]The stock option vests 25% on the first anniversary of the date of the grant, with the remainder vesting in 12 equal quarterly installments thereafter, subject to continued employment with the Company through the applicable vesting date.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT